Related references
Note: Only part of the references are listed.Emergency Use Authorizations of COVID-19-Related Medical Products
Itay Moshkovits et al.
JAMA INTERNAL MEDICINE (2022)
How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
Akihiko Ozaki et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Changes in Drug Utilization After Publication of Clinical Trials and Drug-Related Scandals in Japan: An Interrupted Time Series Analysis, 2005-2017
Shingo Fukuma et al.
JOURNAL OF EPIDEMIOLOGY (2021)
Regulatory changes after the enforcement of the new Clinical Trials Act in Japan
Kenichi Nakamura et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
COMMERCIAL INFLUENCE IN HEALTH: FROM TRANSPARENCY TO INDEPENDENCE Pathways to independence: towards producing and using trustworthy evidence
Ray Moynihan et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Valsartan recall: global regulatory overview and future challenges
Muhammad Junaid Farrukh et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2019)
Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan
Iekuni Ichikawa et al.
ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE (2016)
Japan to learn from biomedical cases
Tetsuya Tanimoto et al.
NATURE (2014)
Novartis faces charges in Japan over promotion of valsartan to doctors
Gavin Blair
BMJ-BRITISH MEDICAL JOURNAL (2014)
Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)
Jun Shiraishi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Combination Effect of Calcium Channel Blocker and Valsartan on Cardiovascular Event Prevention in Patients with High-Risk Hypertension: Ancillary Results of the KYOTO HEART Study
Takahisa Sawada et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2012)
Post-marketing studies of new insulins: sales or science?
Edwin A. M. Gale
BMJ-BRITISH MEDICAL JOURNAL (2012)
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study
Takahisa Sawada et al.
EUROPEAN HEART JOURNAL (2009)
Cardiovascular clinical trials in Japan and controversies regarding prospective randomized open-label blinded end-point design
Takahide Kohro et al.
HYPERTENSION RESEARCH (2009)
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
J Lexchin et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Scope and impact of financial conflicts of interest in biomedical research - A systematic review
JE Bekelman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Share Paper
